Ramhari Kumbhar
Research associate
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (4)
Evidence links air pollution to dementia, yet its role in Lewy body dementia (LBD) remains unclear. In this work, we showed in a cohort of 56.5 million individuals across the United States that fine particulate matter (PM 2.5 ) exposure raises LBD risk. Mechanistically, we found that PM 2.5 exposure led to brain atrophy in wild-type mice, an effect not seen in α-synuclein (αSyn)–deficient mice. PM 2.5 exposure generated a highly pathogenic αSyn strain, PM 2.5 –induced preformed fibril (PM-PFF), with enhanced proteinase K resistance and neurotoxicity, resembling αSyn LBD strains. PM 2.5 samples from China, the United States, and Europe consistently induced proteinase-resistant αSyn strains and in vivo pathology. Transcriptomic analyses revealed shared responses between PM 2.5 -exposed mice and LBD patients, underscoring PM 2.5 ’s role in LBD and stressing the need for interventions to reduce air pollution and its associated neurological disease burden.
Year:
2025
Pathologic α-synuclein (α-syn) spreads from cell-to-cell, in part, through binding to the lymphocyte-activation gene 3 (Lag3). Here we report that amyloid β precursor-like protein 1 (Aplp1) interacts with Lag3 that facilitates the binding, internalization, transmission, and toxicity of pathologic α-syn. Deletion of both Aplp1 and Lag3 eliminates the loss of dopaminergic neurons and the accompanying behavioral deficits induced by α-syn preformed fibrils (PFF). Anti-Lag3 prevents the internalization of α-syn PFF by disrupting the interaction of Aplp1 and Lag3, and blocks the neurodegeneration induced by α-syn PFF in vivo. The identification of Aplp1 and the interplay with Lag3 for α-syn PFF induced pathology deepens our insight about molecular mechanisms of cell-to-cell transmission of pathologic α-syn and provides additional targets for therapeutic strategies aimed at preventing neurodegeneration in Parkinson’s disease and related α-synucleinopathies.
Year:
2024
The spread of prion‐like protein aggregates is a common driver of pathogenesis in various neurodegenerative diseases, including Alzheimer's disease (AD) and related Tauopathies. Tau pathologies exhibit a clear progressive spreading pattern that correlates with disease severity. Clinical observation combined with complementary experimental studies has shown that Tau preformed fibrils (PFF) are prion‐like seeds that propagate pathology by entering cells and templating misfolding and aggregation of endogenous Tau. While several cell surface receptors of Tau are known, they are not specific to the fibrillar form of Tau. Moreover, the underlying cellular mechanisms of Tau PFF spreading remain poorly understood. Here, it is shown that the lymphocyte‐activation gene 3 (Lag3) is a cell surface receptor that binds to PFF but not the monomer of Tau. Deletion of Lag3 or inhibition of Lag3 in primary cortical neurons significantly reduces the internalization of Tau PFF and subsequent Tau propagation and neuron‐to‐neuron transmission. Propagation of Tau pathology and behavioral deficits induced by injection of Tau PFF in the hippocampus and overlying cortex are attenuated in mice lacking Lag3 selectively in neurons. These results identify neuronal Lag3 as a receptor of pathologic Tau in the brain,and for AD and related Tauopathies, a therapeutic target.
Year:
2024
α-Synuclein (α-syn) strains can serve as discriminators between Parkinson’s disease (PD) and related α-synucleinopathies. The relationship between α-syn strain dynamics and clinical performance as patients transition from normal cognition (NC) to cognitive impairment (CI) is not known. Here, we show that the biophysical properties and neurotoxicity of α-syn strains change as PD cognitive status transitions from NC to mild cognitive impairment (PD-MCI) and dementia (PD-D). Both cross-sectional and longitudinal analyses reveal distinct α-syn strains in PD patients correlating to their level of cognitive impairment. Machine learning (ML) was employed to achieve high classification accuracy. The combination of thioflavin T (ThT) maximal fluorescence intensity (mfi), max slope of rise curve (forming rate), lag time (t lag ), 20% time (t 20 ), and half-time (t 50 ), dynamic light scattering (DLS) (peak number, ½ peak size, ½ peak intensity) and neurotoxicity for model training yielded superior performance (90∼99% accuracy in the 4-and 2-classification schema) compared to individual features alone in classifying cognitive status. For the longitudinal study, DLS peak number emerged as the strongest predictor of cognitive transition (HR = 0.12, p = 0.002), with the optimal predictive model combining DLS peak number, sex, DLS peak 1 size, and DLS peak 2 polydispersity achieving high accuracy (C-index of 90%). This study presents evidence that individuals with PD have different α-syn strains correlating to their cognitive status and highlights the potential of α-syn strain dynamics to guide future diagnosis, management, and stratification of PD patients. One Sentence Summary Distinct features of α-syn strains change with cognitive decline in Parkinson’s disease and AI-based analysis incorporating these combined characteristics serves as a powerful predictive tool for PD clinical stratification. Abstract Figure TOC: α-Synuclein strain changes allied with cognitive changes in Parkinson’s disease. Cross-sectional and longitudinal studies show that α-syn strain features (Thioflavin T (ThT), Dynamic light scattering (DLS), and neurotoxicity) change with and before cognitive decline in PD. Machine learning greatly enhances the diagnostic ability to predict PD subtypes and cognitive status.
Year:
2024
Collaborators (16)
Donghoon Kim
Assistant Professor
Dong-A University
Minhan Park
Georgia Institute of Technology
Mina Ryten
University College London
Xuan Zhang
Assistant Professor
University of California Merced
Alexander Pantelyat
Associate Professor
Johns Hopkins University
Valina Dawson
Professor
Johns Hopkins University School of Medicine
Chan Hyun Na
Associate Professor
Johns Hopkins University School of Medicine
Ted M. Dawson
Johns Hopkins University School of Medicine
Nikolay Bliznyuk
University of Florida
Rodney Weber
Georgia Institute of Technology
Xiao Wu
Assistant Professor
Columbia University Mailman School of Public Health
Xiaobo Mao
Associate Professor
Johns Hopkins University School of Medicine
Shizhong Han
Lead Investigator
Johns Hopkins University School of Medicine
david nauen
Johns Hopkins University School of Medicine
Pengfei Liu
Georgia Institute of Technology
Weiyi Peng
Director
University of Houston
Make your next move.
Prepare your application
Review drafts before you send them.